Fibrin-related markers in patients with septic shock: Individual comparison of D-dimers and fibrin monomers impacts on prognosis

Thrombosis and Haemostasis

Volumn 106, Issue 6, 2011, Pages 1228-1230

  Gris, Jean Christophe ^a   Bouvier, Sylvie ^a   Cochery Nouvellon, Eva ^a   Faillie, Jean Luc ^a   Lissalde Lavigne, Géraldine ^a   Lefrant, Jean Yves ^a  

^a NÎMES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; FIBRIN MONOMER;

BLOOD SAMPLING; DISEASE ASSOCIATION; HUMAN; HYPERLACTATEMIA; INTENSIVE CARE UNIT; LETTER; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SEPTIC SHOCK; SURVIVAL RATE;

BIOLOGICAL MARKERS; BLOOD COAGULATION; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; PLASMINOGEN INACTIVATORS; PROGNOSIS; PROTEIN MULTIMERIZATION; RISK; SHOCK, SEPTIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 82555193842     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-07-0489     Document Type: Letter

References (8)

1. Gris JC, Faillie JL, Cochery-Nouvellon E, et al. ISTH overt DIC score in patients with septic shock: automated immunoturbidimetric soluble fibrin assay versus D-dimer assay. J Thromb Haemost 2011; 9: 1252-1255.
2. Thijs LG, de Boer JP, de Groot MC, et al. Coagulation disorders in septic shock. Intensive Care Med 1993; 19 (Suppl 1): S8-15.
3. Massignon D, Lepape A, Bienvenu J, et al. Coagulation/ fibrinolysis balance in septic shock related to cytokines and clinical state. Haemostasis 1994; 2: 36-48.
4. Kidokoro A, Iba T, Fukunaga M, et al. Alterations in coagulation and fibrinolysis during sepsis. Shock 1996; 5: 223-228.
5. Vervloet MG, Thijs LG, Hack CE. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Sem Thromb Hemost 1998; 24: 33-44.
6. Zeerleder S, Schroeder V, Hack CE, et al. TAFI and PAI-1 levels in human sepsis. Thromb Res 2006; 118: 205-212.
7. Hartemink KJ, Hack CE, Groeneveld AB. Relation between coagulation/fibrinolysis and lactate in the course of human septic shock. J Clin Pathol 2010; 63: 1021-1026.
8. Friederich PW, Levi M, Biemond BJ, et al. Novel low-molecualr-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and reduces postthrombolysis thrombi growth in rabbits. Circulation 1997; 96: 916-921.